Cargando…
Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity
In vitro determination of hemolytic properties is a common and important method for preliminary evaluation of cytotoxicity of chemicals, drugs, or any blood-contacting medical device or material. The method itself is relatively straightforward, however, protocols used in the literature vary substant...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917735/ https://www.ncbi.nlm.nih.gov/pubmed/36769243 http://dx.doi.org/10.3390/ijms24032914 |
_version_ | 1784886439207501824 |
---|---|
author | Sæbø, Ingvill Pedersen Bjørås, Magnar Franzyk, Henrik Helgesen, Emily Booth, James Alexander |
author_facet | Sæbø, Ingvill Pedersen Bjørås, Magnar Franzyk, Henrik Helgesen, Emily Booth, James Alexander |
author_sort | Sæbø, Ingvill Pedersen |
collection | PubMed |
description | In vitro determination of hemolytic properties is a common and important method for preliminary evaluation of cytotoxicity of chemicals, drugs, or any blood-contacting medical device or material. The method itself is relatively straightforward, however, protocols used in the literature vary substantially. This leads to significant difficulties both in interpreting and in comparing the obtained values. Here, we examine how the different variables used under different experimental setups may affect the outcome of this assay. We find that certain key parameters affect the hemolysis measurements in a critical manner. The hemolytic effect of compounds tested here varied up to fourfold depending on the species of the blood source. The use of different types of detergents used for generating positive control samples (i.e., 100% hemolysis) produced up to 2.7-fold differences in the calculated hemolysis ratios. Furthermore, we find an expected, but substantial, increase in the number of hemolyzed erythrocytes with increasing erythrocyte concentration and with prolonged incubation time, which in turn affects the calculated hemolysis ratios. Based on our findings we propose an optimized protocol in an attempt to standardize future hemolysis studies. |
format | Online Article Text |
id | pubmed-9917735 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99177352023-02-11 Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity Sæbø, Ingvill Pedersen Bjørås, Magnar Franzyk, Henrik Helgesen, Emily Booth, James Alexander Int J Mol Sci Article In vitro determination of hemolytic properties is a common and important method for preliminary evaluation of cytotoxicity of chemicals, drugs, or any blood-contacting medical device or material. The method itself is relatively straightforward, however, protocols used in the literature vary substantially. This leads to significant difficulties both in interpreting and in comparing the obtained values. Here, we examine how the different variables used under different experimental setups may affect the outcome of this assay. We find that certain key parameters affect the hemolysis measurements in a critical manner. The hemolytic effect of compounds tested here varied up to fourfold depending on the species of the blood source. The use of different types of detergents used for generating positive control samples (i.e., 100% hemolysis) produced up to 2.7-fold differences in the calculated hemolysis ratios. Furthermore, we find an expected, but substantial, increase in the number of hemolyzed erythrocytes with increasing erythrocyte concentration and with prolonged incubation time, which in turn affects the calculated hemolysis ratios. Based on our findings we propose an optimized protocol in an attempt to standardize future hemolysis studies. MDPI 2023-02-02 /pmc/articles/PMC9917735/ /pubmed/36769243 http://dx.doi.org/10.3390/ijms24032914 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sæbø, Ingvill Pedersen Bjørås, Magnar Franzyk, Henrik Helgesen, Emily Booth, James Alexander Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity |
title | Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity |
title_full | Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity |
title_fullStr | Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity |
title_full_unstemmed | Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity |
title_short | Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity |
title_sort | optimization of the hemolysis assay for the assessment of cytotoxicity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917735/ https://www.ncbi.nlm.nih.gov/pubmed/36769243 http://dx.doi.org/10.3390/ijms24032914 |
work_keys_str_mv | AT sæbøingvillpedersen optimizationofthehemolysisassayfortheassessmentofcytotoxicity AT bjørasmagnar optimizationofthehemolysisassayfortheassessmentofcytotoxicity AT franzykhenrik optimizationofthehemolysisassayfortheassessmentofcytotoxicity AT helgesenemily optimizationofthehemolysisassayfortheassessmentofcytotoxicity AT boothjamesalexander optimizationofthehemolysisassayfortheassessmentofcytotoxicity |